| Literature DB >> 30961672 |
Caroline V Ott1,2, Maj Vinberg1, Christopher R Bowie3, Ellen Margrethe Christensen1, Gitte M Knudsen4,5, Lars V Kessing1,5, Kamilla W Miskowiak6,7.
Abstract
Following publication of the original article [1], the authors notified us that a comment in the Peripheral and neural biomarkers and genotype section was incorrectly phrased during editing. "4 weeks of treatment (four active ABCR sessions twice a week or control group sessions twice a week)" should have actually been described as "4 weeks of treatment (4 active, twice a week, ABCR sessions or 2 weekly control group sessions)".Entities:
Year: 2019 PMID: 30961672 PMCID: PMC6452507 DOI: 10.1186/s13063-019-3289-4
Source DB: PubMed Journal: Trials ISSN: 1745-6215 Impact factor: 2.279